Related Experiment Video
Updated: Aug 19, 2025

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
Clinical impact of biofire gastrointestinal panel testing for hospitalised children with acute gastroenteritis
Aviv Sever1, Haim Ben Zvi2,3, Shirel Barnea Melamed1
1Department of Pediatrics C, Schneider Children's Medical Center, Petach Tikva, Israel.
Insights
The BioFire FilmArray Gastrointestinal Panel (FGP) test significantly increased pathogen identification in hospitalized children with diarrhea. This diagnostic tool impacted clinical decisions, particularly for healthy and transplant patients.
Area of Science:
- Pediatric Infectious Diseases
- Clinical Microbiology
- Diagnostic Technology
Background:
- Diarrhoeal episodes are common in hospitalised children.
- Accurate and rapid pathogen identification is crucial for effective treatment.
- Conventional methods may have limitations in detecting diverse gastrointestinal pathogens.
Purpose of the Study:
- To evaluate the clinical impact of BioFire FilmArray Gastrointestinal Panel (FGP) testing.
- To assess the utility of FGP testing in real-life diarrhoeal episodes in paediatric patients.
- To determine if FGP testing influences clinical decision-making and antibiotic prescriptions.
Main Methods:
- Retrospective observation of hospitalised children with diarrhoea between October 2018 and September 2020.
- Collection of demographic, clinical, and stool test data.
- Evaluation of clinical impact by assessing changes in antibiotic prescriptions post-FGP testing.
Main Results:
- FGP testing identified significantly more pathogens (75) compared to conventional methods (25) (p < 0.05).
- Commonly identified pathogens by FGP included Campylobacter, Shigella, Rotavirus, Giardia lamblia, and Cryptosporidium.
- Clinical impact was observed in 12% of cases, with higher rates in previously healthy (19%) and solid organ-transplanted children (15%).
Conclusions:
- BioFire FilmArray Gastrointestinal Panel (FGP) testing enhances pathogen detection in hospitalised children with diarrhoea.
- FGP testing can positively impact clinical decisions, including antibiotic prescribing.
- The diagnostic yield and clinical utility of FGP are particularly notable in immunocompromised and previously healthy paediatric populations.
Aim:
To investigate the clinical impact of BioFire FilmArray Gastrointestinal Panel (FGP) testing in real-life diarrhoeal episodes of hospitalised paediatric patients.
Methods:
Children hospitalised between October 2018 and September 2020 for whom stool specimens for FGP were submitted at the clinician's discretion were retrospectively observed. For each episode, demographics, clinical information and stool tests were collected.
Results:
The clinical impact for each case was evaluated by changing the antibiotic prescription, following the result of the FGP testing. Out of 140 diarrhoeal episodes, 25 pathogens were found in 24 cases using conventional methods, whereas, FGP testing identified 75 pathogens in 56 cases (p < 0.05). The pathogens more frequently identified by FGP testing were Campylobacter, Shigella, Rotavirus, Giardia lamblia and Cryptosporidium. The clinical impact of FGP testing was observed in 17/140 (12%) diarrhoeal episodes, and higher rates in previously healthy (19%) and solid organ-transplanted children (15%).
Conclusion:
We found that using FGP testing for hospitalised children with diarrhoeal episodes could increase pathogen identification and impact clinical decisions, especially in healthy and transplant patients.
More Related Videos
08:32Assessment of Intestinal Transcytosis of Neonatal Escherichia coli Bacteremia Isolates
Published on: February 17, 2023
08:50A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
Published on: June 24, 2020
Related Concept Videos
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Serum Laboratory Studies, Stool Test, Breath Test
Pneumonia III: Complications and Assessment